Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Press Release

Fermented drinks lead Twitter consumer beverage influencers discussion, says GlobalData Influencer Platform

Fermented drinks continue to gain traction in the beverages market driven by growing disposable incomes, rapidly evolving lifestyles and health conscience millennial consumers looking for less sugary and low alcoholic beverages, says leading data and analytics company, According to GlobalData’s ‘Consumer Beverages Influencer Analytics Platform’, beer, wines, sugary drinks and fermented drinks emerged as the […]
Read more

L’Oréal’s presence in Asia will continue to grow, supported by €1,794.2m worth of sales in Q3 2018, says GlobalData

Following L’Oréal’s announcement of their best quarter in 10 years mostly supported by Asian growth, Aleksandrina Yotova, Consumer Analyst at GlobalData, offers her view on the future of the company: “Western Europe remains L’Oréal’s biggest market with €1,855.9m worth of revenue in Q3 2018, which only highlights the importance of the company’s strategy to return […]
Read more

Non-small cell lung cancer market projected to be worth $14.6bn by 2024, says GlobalData

Following the recent spate of approvals in both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), the treatment landscape is becoming increasingly difficult to navigate for both physicians and patients, highlighting the need for better education, access, and infrastructure to support physicians’ and patients’ choices of the optimal therapies, says GlobalData, a […]
Read more

Significant advances in diabetes medicine have been made, but many unmet needs remain, says GlobalData

Advances in diabetes medicine, such as anti-diabetic oral medications, incretin therapies, and novel insulin formulations have been made over the past century, but many unmet needs remain for this complex and difficult-to-treat disease, says GlobalData, a leading data and analytics company. World Diabetes Day (14th November) aims to improve awareness of hyperglycemia (the major hallmark […]
Read more

Six new obesity drugs set to launch by 2026

Multiple big pharma companies are developing new anti-obesity drugs, including Novo Nordisk, Sanofi, and AstraZeneca and six drugs are expected to launch by 2026, according to GlobalData, a leading data and analytics company. The current obesity market is rather sparse, comprising of only six FDA approved drugs on the US market, two EMA approved drugs […]
Read more

Global glioblastoma market set to reach $1.4bn by 2027

The glioblastoma (GBM) market is expected to grow from $662.0m in 2017 to $1.4bn in 2027 across the eight major markets (8MM*) at a compound annual growth rate (CAGR) of 7.5%, according to GlobalData, a leading data and analytics company. The company’s latest report: ‘Glioblastoma Multiforme (GBM) Opportunity Analysis and Forecasts to 2027’ states that […]
Read more

Pancreatic cancer treatment heads in promising direction, says GlobalData

Despite the disappointing history of drug development in pancreatic cancer, the current therapeutic pipeline and clinical development is headed in a promising direction, according to GlobalData, a leading data and analytics company. Drug development has been highly challenging and replete with failure stories of pipeline agents investigated in pancreatic cancer, despite treatment algorithms being dramatically […]
Read more
1 … 41 42 43 44 45 … 61